About

About RevGenetics

RevGenetics is a biotechnology firm that has established itself as a pioneer in the field of longevity and cellular health. Founded in 2007 by Anthony Loera, the company operates at the intersection of rigorous academic research and high performance nutritional supplementation. Unlike many supplement providers that rely on generic formulations, RevGenetics distinguishes itself through translational science: the process of taking cutting edge laboratory discoveries and transforming them into accessible, pharmaceutical grade products for consumers who prioritize long term healthspan.

Leadership & Philosophy

The cornerstone of the RevGenetics business model is a commitment to purity, transparency, and scientific validation driven by Founder and President Anthony Loera. Loera built the company to bridge the gap between academic research and consumer access. Under his leadership, the company gained national recognition as the first to bring Nicotinamide Mononucleotide (NMN) to the United States market in 2014. Loera has been a vocal advocate for consumer rights in the supplement space, recently playing a pivotal role in the 2025 FDA landmark reversal that reaffirmed NMN status as a lawful dietary supplement.

RevGenetics operates with a philosophy that aging is a biological process that can be addressed through targeted molecular intervention. By focusing on NAD+ restoration, telomere maintenance, and mitochondrial optimization, they provide tools for those looking to maintain vitality into their later years.

Scientific Leadership: Dr. Hector Valenzuela

Working in tandem with Loera is Chief Science Officer (CSO) Dr. Hector Valenzuela. Dr. Valenzuela is an acclaimed molecular biologist and researcher who brings a wealth of academic rigor to the RevGenetics formulation process.

Academic Excellence: Dr. Valenzuela holds a Ph.D. from UCLA and currently serves as the Fletcher Jones Chair in Molecular Biology at Whittier College. His dual role as an active academic researcher and a corporate CSO ensures that RevGenetics remains at the absolute forefront of aging science.

Specialization in Immunosenescence: His primary research focus is immunosenescence, which is the study of how the immune system ages and why T cells lose their effectiveness over time. This expertise is critical, as a young immune system is one of the most significant markers of overall longevity.

Telomere Research: Dr. Valenzuela is an expert in Telomere Biology, often describing telomeres as the cellular clock. He was instrumental in refining the Terminal Restriction Fragment (TRF) Assay, a method that allows scientists to measure telomere length with greater precision and speed.

Scientific Contributions: His research has identified critical links between T cell exhaustion and age related conditions like Alzheimers disease. By understanding why memory T cells lose their ability to repair themselves, Dr. Valenzuela helps RevGenetics develop products that target these specific cellular bottlenecks.

Flagship Innovations

The RevGenetics product line is built around high bioavailability and Gold Standard ingredients:

1. DiBerberine 300x: This metabolic support formula addresses the berberine absorption gap using an enteric coated dihydroberberine (DHB) capsule. The DiBerberine 300x Triple-Action Protocol ensures the compound survives stomach acid and is delivered to the small intestine. It features RGBooster1, a patent pending (U.S. App. No. 63/837,080) flavonoid complex derived from Sophora japonica extract that is 300x more potent than piperine at modulating the P-glycoprotein (P-gp) active transport mechanism.

2. Advanced NMN: RevGenetics utilizes a proprietary enteric coated capsule technology. This is vital because NMN can be degraded by stomach acid; the enteric coating ensures the molecule reaches the small intestine intact, where the SLC12A8 transporter can effectively move it into the bloodstream to boost NAD+ levels.

3. MetaCurcumin 277x: Leveraging advanced liquid micelle technology, this product offers up to 277 times the absorption of standard curcumin. It is designed to address systemic inflammation, a key driver of the aging process known as inflammaging.

4. Micronized Resveratrol: Recognizing that standard resveratrol is poorly absorbed, RevGenetics pioneered micronization, which involves reducing particle size to increase surface area and significantly improve bioavailability.

5. Telomere Support (TA-65): As an authorized provider of TA-65, RevGenetics offers one of the few molecules proven in human clinical trials to activate telomerase, the enzyme responsible for lengthening telomeres.

Quality and Safety

RevGenetics operates a Science First supply chain. Every batch of their supplements undergoes third party lab testing to verify potency and ensure the absence of heavy metals or contaminants.